Berardi, Mark http://orcid.org/0000-0003-0491-0952
Brosch, Katharina http://orcid.org/0000-0002-0526-8095
Pfarr, Julia-Katharina
Schneider, Katharina
Sültmann, Angela http://orcid.org/0009-0009-6886-0465
Thomas-Odenthal, Florian
Wroblewski, Adrian http://orcid.org/0000-0002-0371-7686
Usemann, Paula
Philipsen, Alexandra http://orcid.org/0000-0001-6876-518X
Dannlowski, Udo
Nenadić, Igor
Kircher, Tilo
Krug, Axel http://orcid.org/0000-0002-0564-2497
Stein, Frederike
Dietrich, Maria http://orcid.org/0000-0003-2547-5371
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (DA1151/5-1, DA1151/5-2, NE2254/1-2, NE2254/4-1, KI558/14-1, KI558/14-2, FOR 2107, KR3822/5-1, KR3822/7-2)
Article History
Received: 3 February 2023
Revised: 10 August 2023
Accepted: 8 September 2023
First Online: 19 September 2023
Competing interests
: Tilo Kircher received unrestricted educational grants from Servier, Janssen, Recordati, Aristo, Otsuka, neuraxpharm. All other authors declare no conflict of interest and report no biomedical financial interests.